CLINICAL_TRIALS
trial_result
· 2022-12-30
Clinical Trial Update: A Rollover Study to Provide Continued Treatment With Eltrombopag [Phase 4]
Summary
A phase 4 rollover study of eltrombopag to provide continued treatment for thrombocytopaenia has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Novartis Pharmaceuticals | Conditions: Thrombocytopaenia | Phase 4 | Status: COMPLETED | Results posted: 2022-12-30